Difference between revisions of "Team:TecMonterrey GDL/Legal Aspect"
m |
m |
||
| Line 170: | Line 170: | ||
<div class="panel-body "> | <div class="panel-body "> | ||
<div class="col-md-8"> | <div class="col-md-8"> | ||
| − | This document is filled with data of the project representative, data of the physical place where Lactobachill is produced, product specifications (classification, common international denomination, measure unit, therapeutic indications, concentration, usage instructions, etc), sanitary registry of supplies for health and export and import information. | + | <p>This document is filled with data of the project representative, data of the physical place where Lactobachill is produced, product specifications (classification, common international denomination, measure unit, therapeutic indications, concentration, usage instructions, etc), sanitary registry of supplies for health and export and import information.</p> |
</div> | </div> | ||
<div class="col-md-4"> | <div class="col-md-4"> | ||
| Line 193: | Line 193: | ||
<div class="panel-body "> | <div class="panel-body "> | ||
<div class="col-md-8"> | <div class="col-md-8"> | ||
| − | This is accomplished via toxicological studies (acute, chronic, study of the constituents of food that might be affected due to the genetic modification) preclinical studies, clinical studies, allergenicity studies, any interaction that might occur between the modified organism and the food matrix, nutrimental equivalent study as well as all the important parameters for the genetic modification. | + | <p>This is accomplished via toxicological studies (acute, chronic, study of the constituents of food that might be affected due to the genetic modification) preclinical studies, clinical studies, allergenicity studies, any interaction that might occur between the modified organism and the food matrix, nutrimental equivalent study as well as all the important parameters for the genetic modification.</p> |
</div> | </div> | ||
<div class="col-md-4"> | <div class="col-md-4"> | ||
| Line 215: | Line 215: | ||
<div class="panel-body "> | <div class="panel-body "> | ||
<div class="col-md-8"> | <div class="col-md-8"> | ||
| − | The payment is for the request for authorization for commercialization and importation for the marketing of genetically modified organisms | + | <p>The payment is for the request for authorization for commercialization and importation for the marketing of genetically modified organisms |
| − | After the previous steps a special committee deliberates whether the product is suitable for commercialization. | + | After the previous steps a special committee deliberates whether the product is suitable for commercialization.</p> |
</div> | </div> | ||
Revision as of 02:30, 18 October 2018
Legal Aspects
What's necessary?
We spoke with a representative of COFEPRIS (The organism that protects against sanitary risks) to ask the necessary steps for the launch of Lactobachill in Mexico; they showed us the required steps which are the following:
Steps
This document is filled with data of the project representative, data of the physical place where Lactobachill is produced, product specifications (classification, common international denomination, measure unit, therapeutic indications, concentration, usage instructions, etc), sanitary registry of supplies for health and export and import information.
This is accomplished via toxicological studies (acute, chronic, study of the constituents of food that might be affected due to the genetic modification) preclinical studies, clinical studies, allergenicity studies, any interaction that might occur between the modified organism and the food matrix, nutrimental equivalent study as well as all the important parameters for the genetic modification.
The payment is for the request for authorization for commercialization and importation for the marketing of genetically modified organisms After the previous steps a special committee deliberates whether the product is suitable for commercialization.
